Drug Approval | August 02, 2021
Clinical trials in the UK to study the efficacy of Ashwagandha on COVID 19 patients
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The group now has 320 approvals and has so far filed over 400 ANDAs
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
The company has already embarked upon significant expansion in Turkey
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Subscribe To Our Newsletter & Stay Updated
